-
cds.ahrq.gov/sites/default/files/cds/artifact/711/Anthrax%20Post%20Exposure%20Prophylaxis%20Implementation%20Guide%20v2.0%2020190607.pdf
June 07, 2019 - for Clinicians Using the CDS
Exposure to anthrax is rare in the United States (<1 case reported per year
-
cds.ahrq.gov/sites/default/files/cds/artifact/396/cap_1_Recommendations.html
January 01, 1970 - Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults RECOMMENDATIONS Recommendation Hospital admission decision. Imperative: Severity-of-illness scores, such as the CURB-65 criteria (confusion, uremia, respi…
-
cds.ahrq.gov/sites/default/files/workgroups/13461/CDS_Connect_WG_June_2021_Slides_0.pdf
January 01, 2021 - • Can lead to inappropriate responses: 87.3% of high-priority alerts were
overridden in a 1-year sample
-
cds.ahrq.gov/sites/default/files/workgroups/58631/CDS_Connect_Work_Group_February_2022_slides.pdf
January 01, 2022 - Pilot Outcomes
Eligibility Criteria
• Adults over 18 years
• 2 visits and/or new diagnosis in
last year
-
cds.ahrq.gov/sites/default/files/workgroups/28166/CDS_Connect_WG_Summary_August%202021.pdf
August 19, 2021 - artifacts:
• CMS’s Million Hearts® Model Longitudinal ASCVD Risk Assessment Tool for Baseline 10-Year
-
cds.ahrq.gov/sites/default/files/workgroups/226/mar-2017-cholesterol-wg-notes.docx
January 01, 2017 - Title of document or resource
Repository Work Group
Meeting Summary
Date
03/08/2017
Time
1:30 – 3:30 PM ET
AGENDA
· Clarify Details Related to Existing Artifacts
· Logic exclusions, specification of conditions, lookback periods and the inclusion of parameters for scalar values
· Considerations for art…
-
cds.ahrq.gov/sites/default/files/cds/artifact/396/cap_3_DecidExecut.html
January 01, 1970 - Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults TARGET POPULATION Decidable (Y or N) Eligibility Inclusion Criterion Exclusion Criterion RECOMMENDATIONS Recommendation Hospital admission de…
-
cds.ahrq.gov/sites/default/files/cds/artifact/1056/2024_Intervention_Content_Statin_Patient_1.xlsx
January 01, 2024 - Example Intervention Text
Example Patient-Facing Intervention Text: Statin Use for the Primary Prevention of CVD in Adults: Patient-Facing CDS Intervention
General Information
The example intervention text shown below is embedded in the Clinical Quality Language (CQL) files for the Statin Use for the Primary Preven…
-
cds.ahrq.gov/sites/default/files/cds/artifact/396/cap_2_FirstPass%20.html
November 01, 2016 - Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults IDENTITY Citation · Mandell LA, et al. Guidelines for CAP in Adults. CID 2007; 44 Suppl 2S27-S72. Date Released GEM Cut History DEVELOPER Developer Name Conflic…
-
cds.ahrq.gov/sites/default/files/cds/artifact/18/Enhanced%20CDS%20Artifact%20Based%20on%20Pilot%20Implementation_Final.docx
October 01, 2017 - Observation with LOINC code 63895-7 (“Breast feeding [PhenX]”) had answer LA33-6 (“Yes”) within the past year … only semantic clinical drugs (SCDs), since changes made to branded identifiers occur throughout the year
-
cds.ahrq.gov/sites/default/files/workgroups/143366/CDS_Connect_WG_April_2022_Summary.pdf
January 01, 2022 - April 2022 CDS Connect Work Group Summary
Clinical Decision Support (CDS) Connect Work Group (WG)
Meeting Summary
April 21, 2022
3:00 – 4:00 pm ET
Attendees: 31 people, including 6 phone dial-ins
Organization Attendees
AHRQ Sponsors Edwin Lomatan, Mario Teran, Roland Gamache (3)
WG Members Alex Go…
-
cds.ahrq.gov/sites/default/files/cds/artifact/1061/CDS%20Connect_Year%203%20Pilot%20Report_Final.pdf
September 01, 2019 - Each year, the CDS Connect team develops one or more CDS artifacts; implements the CDS in a
healthcare … Of note, the Statin Use for the Primary Prevention of CVD artifact logic requires a calculated
10-year … in 2018 (i.e.,
CMS’s Million Hearts® Model Longitudinal ASCVD Risk Assessment Tool for Baseline 10-
Year … “Diabetes”
• Artifacts: Abnormal Glucose: Screening; Statin Use; Patient-Facing 10-Year
ASCVD Risk
-
cds.ahrq.gov/sites/default/files/cds/artifact/1056/CDS%20Connect_Year%203%20Pilot%20Report_Final.pdf
September 01, 2019 - Each year, the CDS Connect team develops one or more CDS artifacts; implements the CDS in a
healthcare … Of note, the Statin Use for the Primary Prevention of CVD artifact logic requires a calculated
10-year … in 2018 (i.e.,
CMS’s Million Hearts® Model Longitudinal ASCVD Risk Assessment Tool for Baseline 10-
Year … “Diabetes”
• Artifacts: Abnormal Glucose: Screening; Statin Use; Patient-Facing 10-Year
ASCVD Risk
-
cds.ahrq.gov/sites/default/files/cds/artifact/1066/CDS%20Connect_Year%203%20Pilot%20Report_Final.pdf
September 01, 2019 - Each year, the CDS Connect team develops one or more CDS artifacts; implements the CDS in a
healthcare … Of note, the Statin Use for the Primary Prevention of CVD artifact logic requires a calculated
10-year … in 2018 (i.e.,
CMS’s Million Hearts® Model Longitudinal ASCVD Risk Assessment Tool for Baseline 10-
Year … “Diabetes”
• Artifacts: Abnormal Glucose: Screening; Statin Use; Patient-Facing 10-Year
ASCVD Risk
-
cds.ahrq.gov/sites/default/files/cds/artifact/1071/CDS%20Connect_Year%203%20Pilot%20Report_Final.pdf
September 01, 2019 - Each year, the CDS Connect team develops one or more CDS artifacts; implements the CDS in a
healthcare … Of note, the Statin Use for the Primary Prevention of CVD artifact logic requires a calculated
10-year … in 2018 (i.e.,
CMS’s Million Hearts® Model Longitudinal ASCVD Risk Assessment Tool for Baseline 10-
Year … “Diabetes”
• Artifacts: Abnormal Glucose: Screening; Statin Use; Patient-Facing 10-Year
ASCVD Risk
-
cds.ahrq.gov/sites/default/files/cds/artifact/71/CDS%20Connect_Year%203%20Pilot%20Report_Final.pdf
September 01, 2019 - Each year, the CDS Connect team develops one or more CDS artifacts; implements the CDS in a
healthcare … Of note, the Statin Use for the Primary Prevention of CVD artifact logic requires a calculated
10-year … in 2018 (i.e.,
CMS’s Million Hearts® Model Longitudinal ASCVD Risk Assessment Tool for Baseline 10-
Year … “Diabetes”
• Artifacts: Abnormal Glucose: Screening; Statin Use; Patient-Facing 10-Year
ASCVD Risk
-
cds.ahrq.gov/sites/default/files/cds/artifact/1061/2019%20CDS%20Connect_Year%203%20Pilot%20Report_Final.pdf
January 01, 2019 - Each year, the CDS Connect team develops one or more CDS artifacts; implements the CDS in a
healthcare … Of note, the Statin Use for the Primary Prevention of CVD artifact logic requires a calculated
10-year … in 2018 (i.e.,
CMS’s Million Hearts® Model Longitudinal ASCVD Risk Assessment Tool for Baseline 10-
Year … “Diabetes”
• Artifacts: Abnormal Glucose: Screening; Statin Use; Patient-Facing 10-Year
ASCVD Risk
-
cds.ahrq.gov/sites/default/files/cds/artifact/1061/2024_Intervention_Content_Prediabetes_and_Type_2_Diabetes_Part_one_Screening.xlsx
January 01, 2024 - Example Intervention Text
Example Patient-Facing Intervention Text: Prediabetes and Type 2 Diabetes: Part 1, Screening
General Information
The example intervention text shown below is embedded in the Clinical Quality Language (CQL) files for the Prediabetes and Type 2 Diabetes Part One: Screening artifact.
Imple…
-
cds.ahrq.gov/taxonomy/term/34751
July 30, 2021 - Search All AHRQ Sites
Careers
Contact Us
Español
FAQs
Email Updates
-
cds.ahrq.gov/sites/default/files/cds/artifact/171/Occupational%20Factors%20which%20Impact%20Diabetes,%20%20A%20Final%20Knowledge%20Resource%20Report%20(2015).pdf
January 01, 2015 - Sweet, a 35-year-old man with a history of diabetes, hypertension and hyperlipidemia,
presents for … diabetes-basics/
Page 10 of 30
Scenario 2 – Symptomatic Hypoglycemia:
Your patient is a 42-year-old … she ever has taken leave for medical treatment, or how much sick leave she has
taken in the past year